Provectus Biopharmaceuticals (PVCT) SC 13D Provectus Biopharmaceuticals, Inc.

Exhibit 1

JOINT FILING AGREEMENT

In accordance with Rule13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons who executes a copy of this Joint Filing Agreement agrees to the joint filing on behalf of each of them of a Statement on Schedule 13D relating to securities of Provectus Biopharmaceuticals, Inc., and of amendments to that Schedule 13D, and agrees to the filing of this Joint Filing Agreement as an exhibit to the Schedule 13D.

Dated: March 29, 2017		/s/ Charles Littlejohn
		Charles Littlejohn
		/s/ Jeffrey A. Morris
		Jeffrey A. Morris
	By:	/s/ Marilyn Thornton
		Trustee, James F Boyle Jr Credit Shelter Trust
		/s/ John G. Gazonas
		John G. Gazonas
		/s/ James D. Watson
		James D. Watson
	By:	/s/ Christopher Rossman
		Managing Member, Times 11
		/s/ Steve Smith
		Steve Smith
		/s/ al Schwenck
		Al Schwenck
		/s/ Marta Schwenck
		Marta Schwenck
		/s/ Jean Stack
		Jean Stack
		/s/ Bill Reinhard
		Bill Reinhard
		/s/ Scott Webber
		Scott Webber
		/s/ Robert Taurosa
		Robert Taurosa
		/s/ Hugh G. Nolan
		Hugh G. Nolan
		/s/ Marc Kelley
		Marc Kelley
		/s/ Peter R. Culpepper
		Peter R. Culpepper
		/s/ Calvin Wallen III
		Calvin Wallen III
		/s/ Courtlandt G. Miller
		Courtlandt G. Miller